Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Br J Cancer ; 109(8): 2096-105, 2013 Oct 15.
Article in English | MEDLINE | ID: mdl-24064970

ABSTRACT

BACKGROUND: Cisplatin-radiotherapy is a preferred standard for locally advanced, head and neck squamous cell carcinoma (HNSCC). However, the cisplatin-attributable survival benefit is small and toxicity substantial. A biomarker of cisplatin resistance could guide treatment selection and spare morbidity. The ERCC1-XPF nuclease is critical to DNA repair pathways resolving cisplatin-induced lesions. METHODS: In a phase II trial, patients with untreated Stage III-IVb HNSCC were randomised to cisplatin-radiotherapy with/without erlotinib. Archived primary tumours were available from 90 of 204 patients for this planned substudy. Semi-quantitative ERCC1 protein expression (H-score) was determined using the FL297, 4F9, and 8F1 antibodies. The primary analysis evaluated the relationship between continuous ERCC1 protein expression and progression-free survival (PFS). Secondary analyses included two pre-specified ERCC1 cutpoints and performance in HPV-associated disease. RESULTS: Higher ERCC1 expression was associated with inferior PFS, as measured by the specific antibodies FL297 (HR=2.5, 95% CI=1.1-5.9, P=0.03) and 4F9 (HR=3.0, 95% CI=1.2-7.8, P=0.02). Patients with increased vs decreased/normal ERCC1 expression experienced inferior PFS (HR=4.8 for FL297, P=0.003; HR=5.5 for 4F9, P=0.007). This threshold remained prognostic in HPV-associated disease. CONCLUSION: ERCC1-XPF protein expression by the specific FL297 and 4F9 antibodies is prognostic in patients undergoing definitive cisplatin-radiotherapy for HNSCC, irrespective of HPV status.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Biomarkers, Tumor/biosynthesis , Carcinoma, Squamous Cell/enzymology , Carcinoma, Squamous Cell/therapy , Cisplatin/therapeutic use , DNA-Binding Proteins/biosynthesis , Endonucleases/biosynthesis , Head and Neck Neoplasms/enzymology , Head and Neck Neoplasms/therapy , Antibodies, Monoclonal/chemistry , Antibodies, Monoclonal/immunology , Antibody Specificity , Biomarkers, Tumor/analysis , Blotting, Western , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/radiotherapy , Chemoradiotherapy , Cisplatin/administration & dosage , DNA-Binding Proteins/analysis , DNA-Binding Proteins/immunology , DNA-Binding Proteins/metabolism , Endonucleases/analysis , Endonucleases/immunology , Endonucleases/metabolism , Erlotinib Hydrochloride , Female , Head and Neck Neoplasms/drug therapy , Head and Neck Neoplasms/radiotherapy , Humans , Kaplan-Meier Estimate , Male , Proportional Hazards Models , Prospective Studies , Quinazolines/administration & dosage , Squamous Cell Carcinoma of Head and Neck , Treatment Outcome
2.
Ann Oncol ; 21(3): 556-561, 2010 Mar.
Article in English | MEDLINE | ID: mdl-19828561

ABSTRACT

BACKGROUND: Baseline patient and disease characteristics are investigated in non-small-cell lung cancer (NSCLC) in an effort to predict response to treatment and optimize patients' outcomes. Histology has recently been identified in multiple NSCLC phase III trials as a predictive factor for survival in patients receiving pemetrexed regimens. METHODS: Cox-adjusted models were used to further analyze a randomized phase III study in 1725 chemonaive patients with stage IIIB or IV NSCLC and Eastern Cooperative Oncology Group performance status (PS) of zero or one who received cisplatin plus pemetrexed (CP; C, 75 mg/m(2) and P, 500 mg/m(2)) or cisplatin plus gemcitabine (CG; C, 75 mg/m(2) and G, 1250 mg/m(2)) every 21 days. RESULTS: Histology was confirmed to be predictive of CP efficacy and may also be prognostic. Gender, ethnicity, disease stage, smoking status, and PS were not predictive in either treatment arm but were shown to be prognostic in the nonsquamous population, consistent with the results in the overall NSCLC population. CONCLUSIONS: NSCLC histology significantly predicts efficacy outcomes for patients receiving pemetrexed. Several other factors are prognostic for the overall study population as well as a subset of patients with advanced nonsquamous NSCLC.


Subject(s)
Adenocarcinoma/drug therapy , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Large Cell/drug therapy , Carcinoma, Non-Small-Cell Lung/drug therapy , Carcinoma, Squamous Cell/drug therapy , Lung Neoplasms/drug therapy , Adenocarcinoma/pathology , Adolescent , Adult , Aged , Carcinoma, Large Cell/pathology , Carcinoma, Non-Small-Cell Lung/pathology , Carcinoma, Squamous Cell/pathology , Cisplatin/administration & dosage , Deoxycytidine/administration & dosage , Deoxycytidine/analogs & derivatives , Female , Glutamates/administration & dosage , Guanine/administration & dosage , Guanine/analogs & derivatives , Humans , Lung Neoplasms/pathology , Male , Middle Aged , Neoplasm Staging , Pemetrexed , Survival Rate , Treatment Outcome , Young Adult , Gemcitabine
3.
Arq. bras. med. vet. zootec ; 59(6): 1516-1522, dez. 2007. ilus, tab
Article in Portuguese | LILACS | ID: lil-476126

ABSTRACT

Dois estudos foram realizados com vacas lactantes utilizadas como unidade experimental e doadoras de líquido ruminal, sendo as populações de bactérias utilizadas para avaliar a ação de níveis crescentes de lasalocida e monensina na resistência à perda de potássio intracelular, e para produção de gases in vitro. A perda de potássio (Kmax) da lasalocida foi menor para a população de bactérias obtidas do líquido de rúmen de vacas submetidas a dietas com monensina, óleo de soja e monensina mais óleo de soja (19,4 a 25,4 por cento) quando comparada com a perda de potássio em vacas submetidas a dietas sem ionóforo e óleo de soja (30,1 por cento). O mesmo ocorreu para a perda de potássio da monensina, em que o menor valor foi de 6,5 por cento para monensina mais óleo e o maior, de 29,5 por cento, para o controle. Necessita-se de alta concentração de monensina (Kd= 2,3µM), porém baixa de lasalocida (Kd= 0,2µM) para causar a metade da perda máxima de potássio intracelular da população de bactérias do rúmen de vacas submetidas a dietas com monensina. As populações de bactérias de vacas submetidas às dietas com monensina foram sensíveis à lasalocida. As amostras incubadas com própolis produziram menor volume de gases (12,9ml/100g de MS)


Two studies were carried out with lactating cows as experimental units and ruminal fluid donors. The ruminal bacteria population was used to evaluate the action of increasing levels of lasalocid and monensin on resistance of intracellular potassium depletion and in vitro gas production intracellular depletion potassium (Kmax) of lasalocid was lower to ruminal bacteria population obtained from rumen of cows fed diets with monensin, soybean oil and monensin plus soybean oil (19.4 to 25.4 percent) when compared to cows fed with control diet (30.1 percent). The same occurred for intracellular depletion potassium (Kmax) of monensin, in which the lowest value was 6.5 percent to monensin plus soybean oil and the greatest was 29.5 percent to control. High monensin concentration (Kd= 2.3µM) and low lasalocid concentration (Kd= 0.2µM) were necessary to cause half of maximum potassium depletion in ruminal bacteria population from cows fed diet with monensin. The ruminal bacteria population from cows feed diet with monensin were sensible to lasalocid. In vitro gas production showed the lowest volume when diets were incubated with propolis (12,9ml/100g of DM)


Subject(s)
Animals , Female , Cattle , Potassium Channels/pharmacokinetics , Flatulence/chemically induced , Flatulence/veterinary , Ionophores/administration & dosage , Lasalocid/administration & dosage , Lasalocid/pharmacokinetics , Monensin/administration & dosage , Monensin/pharmacokinetics
4.
Arq. bras. med. vet. zootec ; 57(6): 778-783, dez. 2005. tab, graf
Article in Portuguese | LILACS, VETINDEX | ID: biblio-1462578

ABSTRACT

Em dois estudos, o líquido ruminal de bovinos mantidos sob pastagem foi usado para incubação in vitro em diferentes meios artificiais com valores de pH 5,5 e 7,0, para avaliar a ação de níveis crescentes de monensina na resistência à perda de potássio de bactérias do rúmen e verificar o efeito de monensina e lasalocida na produção de amônia e de proteína microbiana em pH 5,5 e 7,0. O meio utilizado para determinar a perda de potássio interferiu nos valores absolutos de potássio. A concentração de monensina necessária para causar a metade da perda máxima de potássio foi de 2,77µM em pH 5,5 e 0,056µM em pH 7,0, evidenciando que as bactérias incubadas em meios com pH 5,5 foram mais resistentes à monensina que aquelas incubadas em meios com pH 7,0. Os ionóforos e a acidez do meio reduziram a produção de amônia, e não se observou interação entre eles. Os ionóforos, independente do pH, inibiram a produção de amônia em 56%. A acidez inibiu a produção de amônia em 50,5%, independente do ionóforo. Os efeitos dos ionóforos e da acidez foram aditivos quando a inibição máxima ocorreu pelo uso de ionóforos com pH baixo (75,2%). A produção de proteína microbiana foi menor quando a lasalocida estava presente no meio de cultura com baixo valor de pH.


Ruminal fluid from steers fed on pasture was incubated with artificial media at pH 5.5 and 7.0 in two experiments. In the first, the effect of monensin level on resistance of ruminal bacteria to potassium depletion was evaluated; in the second, effects of the ionophores monensin and lasalocid on ammonia and protein production were quantified. In experiment 1, culture media affected potassium level. The monensin concentration needed to cause half maximal potassium depletion was 2.77µM at pH 5.5 but was 0.056µM at pH 7.0, showing that bacteria incubated at pH 5.5 were more tolerant to monensin than those incubated at pH 7.0. Both ionophores as well as increased acidity caused decreased ammonia production. Both ionophores inhibited ammonia production by 56%, independently of pH. In cultures incubated at pH 5.5 compared to pH 7.0, ammonia production was decreased by 50.5%, independently of the ionophores. Therefore, effects of ionophores and acidity were additive, and the maximum inhibition occurred in the presence of an ionophore at low pH (75.2%). Microbial protein production was lowest when lasalocid was present in a low pH culture medium, causing inhibition of microbial growth.


Subject(s)
Cattle , Animal Nutritional Physiological Phenomena , Lasalocid/administration & dosage , Pasture , Rumen
5.
Arq. bras. med. vet. zootec ; 57(6): 777-783, dez. 2005. ilus, tab
Article in Portuguese | LILACS | ID: lil-436500

ABSTRACT

Em dois estudos, o líquido ruminal de bovinos mantidos sob pastagem foi usado para incubação in vitro em diferentes meios artificiais com valores de pH 5,5 e 7,0, para avaliar a ação de níveis crescentes de monensina na resistência à perda de potássio de bactérias do rúmen e verificar o efeito de monensina e lasalocida na produção de amônia e de proteína microbiana em pH 5,5 e 7,0. O meio utilizado para determinar a perda de potássio interferiu nos valores absolutos de potássio. A concentração de monensina necessária para causar a metade da perda máxima de potássio foi de 2,77µM em pH 5,5 e 0,056µM em pH 7,0, evidenciando que as bactérias incubadas em meios com pH 5,5 foram mais resistentes à monensina que aquelas incubadas em meios com pH 7,0. Os ionóforos e a acidez do meio reduziram a produção de amônia, e não se observou interação entre eles. Os ionóforos, independente do pH, inibiram a produção de amônia em 56%. A acidez inibiu a produção de amônia em 50,5%, independente do ionóforo. Os efeitos dos ionóforos e da acidez foram aditivos quando a inibição máxima ocorreu pelo uso de ionóforos com pH baixo (75,2%). A produção de proteína microbiana foi menor quando a lasalocida estava presente no meio de cultura com baixo valor de pH.


Subject(s)
Animal Nutritional Physiological Phenomena , Cattle , Lasalocid/administration & dosage , Pasture , Rumen
6.
Arq. bras. med. vet. zootec ; 57(supl.2): 212-219, set. 2005. tab
Article in Portuguese | LILACS | ID: lil-432015

ABSTRACT

Avaliaram-se os efeitos do níquel e da concentração protéica da dieta sobre o consumo e a digestibilidade aparente da matéria seca (MS), proteína bruta (PB) e energia, e balanço de nitrogênio do feno de Brachiaria brizantha cv. Marandu, oferecido a ovinos. As dietas testadas foram: A- feno; B- feno + níquel; C- feno + mistura protéica; D- feno + níquel + mistura protéica. As dietas continham, respectivamente 0,2, 5,2, 0,5 e 5,5ppm de níquel e 3,1, 3,1, 8,2 e 8,2 de PB. Nos níveis com menor concentração protéica (A e B; 3,1 PB), não foi observado efeito do níquel sobre o consumo e a digestibilidade aparente de matéria seca, energia e proteína, assim como os balanços protéico e energético. Nos com maior concentração protéica (C e D; 8,2 PB), o uso do níquel resultou em menor consumo de MS digestível, energia digestível e energia metabolizável. A maior concentração protéica teve efeito positivo sobre as caracteristicas avaliadas, índependentemente da suplementação ou não com níquel, com exceção da digestibilidade aparente da energia bruta, semelhantes entre as dietas B e D.


Subject(s)
Animals , Animal Nutritional Physiological Phenomena , Brachiaria/adverse effects , Sheep
7.
Arq. bras. med. vet. zootec ; 56(5): 658-664, out. 2004. tab
Article in Portuguese | LILACS | ID: lil-392730

ABSTRACT

Estimou-se a degradabilidade in situ de 10 forrageiras tropicais em três idades ao corte (21, 42 e 63 dias) e em três tempos de incubação (6, 24 e 96h). As forrageiras utilizadas foram: Andropogon gayanus cv. Planaltina, Brachiaria brizantha (acessos 3401, 3413 e 3451 CPAC), Cenchrus ciliaris (acessos 79119, 79146, 79148, 80199 e 81302 CPATSA) e Panicum maximum (3616 CPAC). Os acessos de B. brizantha, P. maximum e A. gayanus apresentaram os maiores valores de degradabilidade da matéria seca e os de C. ciliaris os valores mais baixos. Todas as forrageiras apresentaram queda no desaparecimento da matéria seca com o avanço da idade. Os acessos de Brachiaria brizantha 3413 e 3451 apresentaram as maiores degradabilidades efetivas.


Subject(s)
Animals , Cattle , Dietary Fiber , Poaceae
8.
Arq. bras. med. vet. zootec ; 55(3): 341-345, jun. 2003. tab
Article in Portuguese | LILACS | ID: lil-350614

ABSTRACT

Avaliaram-se o consumo e a digestibilidade aparente da matéria seca, da proteína bruta e da energia e o balanço de nitrogênio de silagens dos sorgos BR601, BR700, BR701 e AG2002 em ovinos. O consumo de matéria seca e de energia bruta näo diferiu entre os híbridos. Quanto à digestibilidade aparente da matéria seca e da energia bruta e ao consumo de matéria seca digestível e de energia digestível, observaram-se maiores valores para o BR601. O maior consumo de proteína bruta foi observado no BR700 e o menor no AG2002. A maior digestibilidade aparente da proteína bruta ocorreu para o BR601 e a menor para o BR701. O consumo de proteína digestível foi maior para os híbridos BR601 e BR700. Todos os tratamentos apresentaram balanço de nitrogênio positivo e näo diferiram entre si.


Subject(s)
Animals , Animal Nutritional Physiological Phenomena , Edible Grain , Proteins , Sheep , Silage
9.
Arq. bras. med. vet. zootec ; 55(3): 346-349, jun. 2003. tab
Article in Portuguese | LILACS | ID: lil-350615

ABSTRACT

Avaliaram-se o consumo e a digestibilidade aparente das fraçöes fibrosas de silagens dos sorgos BR601, BR700, BR701 e AG2002. O maior consumo de fibra em detergente neutro (FDN) foi observado com as silagens dos híbridos BR701 e BR601 (P<0,05), e o consumo da silagem do híbrido BR700 näo diferiu do consumo das demais silagens. A maior digestibilidade aparente da FDN foi obtida com o BR601 (P<0,05) e a menor com o BR700 (P<0,05). O maior consumo de FDN digestível ocorreu no BR601 (P<0,05). Com BR700 e AG2002 ocorreu o menor consumo de FDN digestível (P<0,05). O maior consumo de fibra em detergente ácido (FDA) foi observado no híbrido BR700 e o menor no AG2002 (P<0,05). As silagens dos híbridos BR601 e BR700 apresentaram digestibilidade aparente da FDA maior do que a da silagem do AG2002 (P<0,05). O maior consumo de FDA digestível foi observado com o BR700 e o menor com o AG2002 (P<0,05). O maior consumo de celulose foi observado na silagem do BR700 e o menor na silagem do AG2002 (P<0,05). Näo foram observadas diferenças entre híbridos quanto à digestibilidade aparente da celulose. O consumo de celulose digestível foi maior com os híbridos BR700, BR601 e BR701 (P<0,05) e menor com o AG2002 (P<0,05). O maior consumo de hemicelulose foi obtido com o BR601 (P<0,05). Näo houve diferenças entre os híbridos quanto à digestibilidade aparente da hemicelulose e ao consumo de hemicelulose digestível. O maior consumo de lignina foi observado no híbrido BR700 (P<0,05). Os menores consumos de lignina foram observados no BR601 e AG2002 (P<0,05).


Subject(s)
Animals , Animal Nutritional Physiological Phenomena , Dietary Fiber , Edible Grain , Sheep , Silage
11.
J Am Coll Surg ; 185(4): 388-97, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9328388

ABSTRACT

BACKGROUND: Most reports regarding the treatment of thyroid cancer originate from university referral centers. In this article, we report our experience in managing thyroid cancer of follicular cell origin at a non-university institution over a 26-year period. STUDY DESIGN: We reviewed the medical records of all patients treated for thyroid cancer at the Gundersen/Lutheran Medical Center from 1969 to 1995. Histologic types, demographic and clinical characteristics, laboratory results, treatment, complications, and followup observations were tabulated. Risk was assigned according to the age, presence of distant metastasis, extent of the primary tumor, and site of the primary tumor (AMES) staging system. RESULTS: The histologic classification was as follows: papillary, 139; follicular, 24; Hürthle cell, 14; and anaplastic, 11. Low-risk lesions were identified in 96%, 79%, and 71% of the patients with papillary, follicular, and Hürthle cell (collectively designated differentiated) carcinoma, respectively. We treated 60% of our patients with differentiated thyroid cancer with near-total or total thyroidectomy. Clinically involved cervical lymph nodes were removed singly or by modified neck dissection. We frequently ablated thyroid remnants after operation with 29.9 mCi (1,110 MBq) of 131I, after which we treated the patient with suppressive doses of levothyroxine. Patients were evaluated yearly with thyroglobulin measurements and, in some high-risk patients, with total-body 131I scans. Cancer recurred in 13%, 8%, and 7% of our patients with papillary, follicular, and Hürthle cell carcinoma, respectively. Only three patients died of differentiated thyroid cancer; eight are alive with malignancy. In anaplastic thyroid cancer, cervical lymph node metastases, local invasion, and distant metastases were present in 18%, 64%, and 45% of patients at the time of initial evaluation. Total or near-total thyroidectomy was possible in only four of nine patients treated surgically. External radiation (11 patients) and chemotherapy (two patients) were used. Additional metastases developed in 45% of the patients, and nine patients died within a year. Permanent hypoparathyroidism or hoarseness complicated 2.7% of the thyroid operations. CONCLUSIONS: Although our followup was relatively short, the results of treating thyroid cancer by general surgeons at a nonuniversity hospital compare favorably with results obtained from university referral centers.


Subject(s)
Adenocarcinoma, Follicular/surgery , Carcinoma, Papillary/surgery , Thyroid Neoplasms/surgery , Thyroidectomy , Adenocarcinoma/diagnostic imaging , Adenocarcinoma/surgery , Adenocarcinoma, Follicular/diagnostic imaging , Adolescent , Adult , Aged , Aged, 80 and over , Carcinoma, Papillary/diagnostic imaging , Child , Child, Preschool , Combined Modality Therapy , Female , Humans , Lymphatic Metastasis , Male , Middle Aged , Neoplasm Recurrence, Local , Radionuclide Imaging , Retrospective Studies , Thyroid Neoplasms/diagnostic imaging , Thyroid Neoplasms/pathology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...